Money Matters - Simplified


FDA clears vandetanib for treatment of rare thyroid cancer

British pharmaceutical giant AstraZeneca Plc got the green signal from the U.S. Food and Drug Administration (FDA) Wednesday, for its new drug vandetanib for the treatment of a rare form of thyroid cancer.

FDA approves Benlysta, first drug to treat lupus in 56 years

The Food and Drug Administration (FDA) has cleared Benlysta, the first new drug to treat lupus in 56 years, designed to relieve flare-ups and pain in certain patients who are receiving standard therapy for the deadly autoimmune disease.

Chilli cakes, chocolates to burn off calories

Ever imagined losing weight through chocolates and cakes? Well, mouth-watering desserts to help people shed flab is soon going to become a reality.

FDA grants hearing to Genentech over breast cancer drug

Genentech, a Roche subsidiary, has been informed through a letter by the Food and Drug Administration (FDA) that the federal agency is ready to give another chance to the company to argue in favour of of ‘Avastin’ a drug for breast cancer.

FDA gives nod to first 3-D mammography imaging system

On Friday, the Food and Drug Administration (FDA) granted approval to Selenia Dimensions digital breast tomosynthesis system marketed by Hologic Inc. of Bedford, Mass., the first such device to be sold in the nation that will produce three-dimensional images of the breast for cancer screening and diagnosis.

FDA approves Makena for reducing risk of preterm birth

Finally a drug option to prevent preterm births. Researchers claim that it can help at-risk pregnant women reach full term.

2010 FDA Approvals and a Look Ahead

 Anyone who's kept an eye on the drugmakers this year won't be surprised by this statistic: The Food and Drug Administration approved fewer drugs this year than it has since 2007. According to the Wall Street Journal, which took the time to add them all up, the FDA only approved 21 drugs this year, compared with 25 in 2009 and 24 in 2008.


FDA okays Gardasil for anal cancer prevention

In what can be termed as significant step in the prevention of anal cancer, the U.S. Food and Drug Administration (FDA) has given regulatory approval to Gardasil, a human papillomavirus vaccine.

Our Drug Is Better Than Your Drug

"I am highly confident that at the end of the day, when all the cards are on the table, we will be, not only the JAK1 and 2 inhibitor that is two to three years ahead of any potential competition, but that we have the best compound."
-- Paul Friedman, President and CEO of Incyte (Nasdaq: INCY). Shares Plunged: What You Need to Know

 Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.